About Phebra
Phebra is a company based in Lane Cove (Australia) founded in 1993. It operates as a B2B. Phebra operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
- Headquarter Lane Cove, Australia
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website phebra.com
People of Phebra
4 people are tracked at Phebra (2 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Andre Vlok | Chief Executive Officer | Leadership |
Robert Ingui | Chief Financial & Commercial Services Officer | Leadership |
Andrew Hawthorne | Supply Chain Manager | Team |
Kelly Lawrence | People And Culture Manager | Team |
Complete people profiles for Phebra
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Phebra
Phebra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| zambon.com | 1906 | Bresso, Italy | – | – | APIs and finished drugs are developed and manufactured in pharmaceuticals. | |
| aenova-group.com | 2008 | Starnberg, Germany | – | – | CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided. | |
| leukocare.com | 2003 | Munich, Germany | $17.5M | 70 | Proprietary stabilizing solutions for biologics formulations are developed. |
Detailed competitors of Phebra
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Phebra
Websites that share an audience with Phebra (phebra.com).
Websites whose visitors overlap most with Phebra. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| acrux.com.au | 90% | 3.7K | #7,741,592 | View details | |
| maynepharma.com | 73% | 18.6K | #918,677 | View details |
Latest news on Phebra
Complete news archive for Phebra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Phebra
10 companies that operate in the same segment as Phebra (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Phebra
Phebra was founded in 1993.
Phebra is headquartered in Lane Cove, Australia. It is registered at Lane Cove, New South Wales, Australia.
Phebra, established in 1993, excels in providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug production. Produces high-quality pharmaceutical products, including tablets, capsules, creams, syrups, and injectables. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Phebra's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.